Filter News
Area of Research
- (-) Isotopes (6)
- (-) Nuclear Science and Technology (12)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (22)
- Clean Energy (16)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (3)
- Fusion and Fission (6)
- Fusion Energy (8)
- Materials (22)
- Materials for Computing (6)
- National Security (6)
- Neutron Science (21)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (8)
- Supercomputing (73)
News Type
News Topics
- (-) Advanced Reactors (10)
- (-) Biomedical (8)
- 3-D Printing/Advanced Manufacturing (4)
- Bioenergy (1)
- Climate Change (1)
- Computer Science (3)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (1)
- Environment (1)
- Fusion (8)
- Irradiation (1)
- Isotopes (30)
- Materials (4)
- Materials Science (5)
- Molten Salt (4)
- National Security (1)
- Neutron Science (4)
- Nuclear Energy (36)
- Physics (2)
- Security (1)
- Space Exploration (9)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
After retiring from Y-12, Scott Abston joined the Isotope Science and Engineering Directorate to support isotope production and work with his former manager. He now leads a team maintaining critical equipment for medical and space applications. Abston finds fulfillment in mentoring his team and is pleased with his decision to continue working.
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
A developing method to gauge the occurrence of a nuclear reactor anomaly has the potential to save millions of dollars.
As CASL ends and transitions to VERA Users Group, ORNL looks at the history of the program and its impact on the nuclear industry.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.